Bionano Genomics, Inc. (Nasdaq: BNGO) announced a peer-reviewed study published in Molecular Therapy - Methods & Clinical Development, describing the application of optical genome mapping (OGM) to ...
ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...
Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that the Aventa™ Lymphoma test ...
Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...
REVEAL GENOMICS, S.L. is a Barcelona-based biotechnology company that discovers, develops, and markets innovative diagnostic ...
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at ...
Genomic medicine has the potential to impact all areas of medicine and change clinical practice. In contrast to the trial-and-error of today’s practice, genomic ...
Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...
The ACMG Foundation for Genetic and Genomic Medicine (ACMGF) has announced that John C. Carey, MD, MPH, FACMG, FAAP, a globally respected clinical geneticist, educator, editor, and advocate, has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results